Literature DB >> 12579991

Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene.

Justin E Sausville1, Rita G Salloum, Lynn Sorbara, Douglas W Kingma, Mark Raffeld, Robert J Kreitman, Paula D Imus, David Venzon, Maryalice Stetler-Stevenson.   

Abstract

We studied 86 specimens from 24 patients with hairy cell leukemia (HCL) to determine the sensitivity of routine flow cytometry (FC) and consensus primer PCR (cpPCR) in this disease. FC was more sensitive, detecting HCL in 48 (56%) of 86 specimens, while clonal B-cell populations were detected by cpPCR in only 23 (27%) of 86 specimens. FC and cpPCR were both more sensitive than morphologic examination. A positive cpPCR result is associated with higher tumor cell numbers than a negative cpPCR result, as determined by FC (P = .0017). We determined cutoff values for number of tumor cells at which cpPCR is consistently positive. At 6.8 tumor cells per microliter, cpPCR would be expected to be positive in at least 90% of the samples. FC was adequate in 86 cases (100%), while cpPCR was adequate in 74 cases (86%). FC is superior to cpPCR for detecting minimal residual HCL. It is more sensitive and more specific and permits quantitation of tumor cell number.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12579991     DOI: 10.1309/G629-9513-NGLC-UB1K

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  20 in total

Review 1.  Hairy cell leukemia.

Authors:  Ronan Swords; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  PRAME expression in hairy cell leukemia.

Authors:  Evgeny Arons; Tara Suntum; Inger Margulies; Constance Yuan; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Leuk Res       Date:  2008-03-04       Impact factor: 3.156

3.  Immunophenotypic aberrancy of a case of hairy cell leukemia.

Authors:  Abhishek Purohit; S Venkatesan; Mukul Aggarwal; Jasdeep Singh; Rahul Sharma; Manoranjan Mahapatra; Hara P Pati; Renu Saxena
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-20       Impact factor: 0.900

4.  Flow cytometric immunophenotypic assessment of T-cell clonality by Vβ repertoire analysis: detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapy.

Authors:  Prashant Tembhare; Constance M Yuan; Liqiang Xi; John C Morris; David Liewehr; David Venzon; John E Janik; Mark Raffeld; Maryalice Stetler-Stevenson
Journal:  Am J Clin Pathol       Date:  2011-06       Impact factor: 2.493

5.  Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.

Authors:  Dai Chihara; Evgeny Arons; Maryalice Stetler-Stevenson; Constance M Yuan; Hao-Wei Wang; Hong Zhou; Mark Raffeld; Liqiang Xi; Seth M Steinberg; Julie Feurtado; Lacey James; Wyndham Wilson; Raul C Braylan; Katherine R Calvo; Irina Maric; Alina Dulau-Florea; Robert J Kreitman
Journal:  J Clin Oncol       Date:  2020-02-28       Impact factor: 44.544

6.  Bendamustine and rituximab in relapsed and refractory hairy cell leukemia.

Authors:  Mauricio Burotto; Maryalice Stetler-Stevenson; Evgeny Arons; Hong Zhou; Wyndham Wilson; Robert J Kreitman
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

Review 7.  Hairy cell leukemia: Past, present and future.

Authors:  Bartlomiej M Getta; Jae H Park; Martin S Tallman
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-21       Impact factor: 3.020

8.  Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.

Authors:  Haipeng Shao; Katherine R Calvo; Marlene Grönborg; Prashant R Tembhare; Robert J Kreitman; Maryalice Stetler-Stevenson; Constance M Yuan
Journal:  Leuk Res       Date:  2013-01-22       Impact factor: 3.156

Review 9.  Hairy Cell Leukemia.

Authors:  Rossella Riccioni; Sara Galimberti; Mario Petrini
Journal:  Curr Treat Options Oncol       Date:  2007-04

10.  Soluble CD22 as a tumor marker for hairy cell leukemia.

Authors:  Kakushi Matsushita; Inger Margulies; Masanori Onda; Satoshi Nagata; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Blood       Date:  2008-07-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.